Gene Expression Profiling of Early Renal Toxicity Induced by Gentamicin in Mice

  • Oh, Jung-Hwa (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Park, Han-Jin (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Lim, Jung-Sun (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Jeong, Sun-Young (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Hwang, Ji-Yoon (Toxicogenomics Team, Korea Institute of Toxicology) ;
  • Kim, Yong-Bum (Clinical Pathology Team, Korea Institute of Toxicology) ;
  • Yoon, Seok-Joo (Toxicogenomics Team, Korea Institute of Toxicology)
  • Published : 2006.09.30

Abstract

To elucidate the molecular mechanisms associated with early renal injury induced by gentamicin, the most commonly used antibiotics worldwide in the treatment of Gram-negative bacterial infections. We have identified genes differentially expressed at different duration of gentamicin administration. C57BL/6 female mice were treated daily with gentamicin (20 mg/kg, 100 mg/kg, and 200mg/kg) for 7 days and then sacrificed at day 1, 3, and 7 after administration. Standard blood biochemistry and histopathological observation indicative of nephrotoxicity were made. Total RNA was extracted from the kidney for microarray analysis using Affymetrix $GeneChip^{\circledR}$. Five hundred and seventy eight genes were identified as being either up-or down-regulated over 2-fold changes during early renal injury (p<0.05) and were analyzed by hierarchical clustering. The results showed that the genes involved in early immune responses were differentially regulated during early renal injury. Principal component analysis (PCA) confirmed sample separation according to the degree of renal toxicity. In addition, we identified two potential biomarkers that may predict early renal toxicity. This data may contribute to elucidate of the genetic events during early renal injury and to discover the potential biomarkers for nephrotoxicity induced by gentamicin.

Keywords

References

  1. Ali, B.H. Gentamicin nephrotoxicity in humans and animals: some recent research. Gen. Pharmacol. 26 (7), 1477-1487 (1995) https://doi.org/10.1016/0306-3623(95)00049-6
  2. Vera-Roman, J., Krishnakantha, T.P. & Cuppage, F.E. Gentamicin nephrotoxicity in rats. I. Acute biochemical and ultrastructural effects. Lab. Invest. 33(4), 412-417 (1975)
  3. Saito, H., Inui, K. & Hori, R. Mechanisms of gentamicin transport in kidney epithelial cell line (LLCPK1). J. Pharmacol. Exp. Ther. 1071-1076 (1986)
  4. Molitoris, B.A. Cell biology of aminoglycoside nephrotoxicity: newer aspects. Curr. Opin. Nephrol. Hypertens. 6(4), 384-388 (1997) https://doi.org/10.1097/00041552-199707000-00013
  5. Hamadeh, H.K. et al. Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. 67(2), 232-240 (2002) https://doi.org/10.1093/toxsci/67.2.232
  6. Hamadeh, H.K. et al. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67(2), 219-231 (2002) https://doi.org/10.1093/toxsci/67.2.219
  7. Waring, J.F. et al. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120(1-3), 359-368 (2001) https://doi.org/10.1016/S0378-4274(01)00301-0
  8. Huang, Q. et al. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol. Sci. 63(2), 196-207 (2001) https://doi.org/10.1093/toxsci/63.2.196
  9. Nagasawa, Y. et al. Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis. Nephrol. Dial. Transplant. 16 (5), 923-931 (2001) https://doi.org/10.1093/ndt/16.5.923
  10. Yoshida, T. et al. Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney Int. 61(5), 1646-1654 (2002) https://doi.org/10.1046/j.1523-1755.2002.00341.x
  11. Amin, R.P. et al. Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 112(4), 465-479 (2004) https://doi.org/10.1289/ehp.6683
  12. Thukral, S.K. et al. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol. Pathol. 33(3), 343-355 (2005) https://doi.org/10.1080/01926230590927230
  13. Duarte, C.G. & Preuss, H.G. Assessment of renal function--glomerular and tubular. Clin. Lab. Med. 13 (1), 33-52 (1993)
  14. Takeda, K. & Akira, S. TLR signaling pathways. Semin. Immunol. 16, 3-9 (2004) https://doi.org/10.1016/j.smim.2003.10.003
  15. Davis, J.W. et al. Quantitative gene expression analysis in a nonhuman primate model of antibioticinduced nephrotoxicity. Toxicol. Appl. Pharmacol. 200(1), 16-26 (2004) https://doi.org/10.1016/j.taap.2004.02.001
  16. bone-Larson, C.L. et al. IFN-gamma-inducible protein- 10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J. Immunol. 167(12), 7077-7083 (2001) https://doi.org/10.4049/jimmunol.167.12.7077
  17. Zimmers, T.A. et al. Growth differentiation factor- 15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 23(6), 543-548 (2005)
  18. Hwang, J.Y. et al. Toxicogenomics study on ${\alpha}$-Naphthylisothiocyanate induced hepatotoxicity in mice. Mol. Cell. Toxicol. 2(1), 48-53 (2006)
  19. Kanehisa, M. et al. The KEGG resource for deciphering the genome. Nucleic Acids Res. 32 (Database issue), D277-280 (2004) https://doi.org/10.1093/nar/gkh063